Klopstock T - Search Results

1

Creatine supplementation lowers brain glutamate levels in Huntington's disease.

Bender A, Auer DP, Merl T, Reilmann R, Saemann P, Yassouridis A, Bender J, Weindl A, Dose M, Gasser T, Klopstock T. Bender A, et al. Among authors: klopstock t. J Neurol. 2005 Jan;252(1):36-41. doi: 10.1007/s00415-005-0595-4. J Neurol. 2005. PMID: 15672208 Clinical Trial.

2

Markedly different course of Friedreich's ataxia in sib pairs with similar GAA repeat expansions in the frataxin gene.

Klopstock T, Chahrokh-Zadeh S, Holinski-Feder E, Meindl A, Gasser T, Pongratz D, Müller-Felber W. Klopstock T, et al. Acta Neuropathol. 1999 Feb;97(2):139-42. doi: 10.1007/s004010050966. Acta Neuropathol. 1999. PMID: 9928824

3

[Genetic counseling and prenatal diagnosis in mitochondrial diseases].

Klopstock T, Gasser T. Klopstock T, et al. Nervenarzt. 1999 Jun;70(6):504-8. doi: 10.1007/s001150050472. Nervenarzt. 1999. PMID: 10412694 Review. German.

4

Age and cause of death in mitochondrial diseases.

Klopstock T, Jaksch M, Gasser T. Klopstock T, et al. Neurology. 1999 Sep 11;53(4):855-7. doi: 10.1212/wnl.53.4.855. Neurology. 1999. PMID: 10489054

5

Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study.

Walter MC, Lochmüller H, Reilich P, Klopstock T, Huber R, Hartard M, Hennig M, Pongratz D, Müller-Felber W. Walter MC, et al. Among authors: klopstock t. Neurology. 2000 May 9;54(9):1848-50. doi: 10.1212/wnl.54.9.1848. Neurology. 2000. PMID: 10802796 Clinical Trial.

6

A placebo-controlled crossover trial of creatine in mitochondrial diseases.

Klopstock T, Querner V, Schmidt F, Gekeler F, Walter M, Hartard M, Henning M, Gasser T, Pongratz D, Straube A, Dieterich M, Müller-Felber W. Klopstock T, et al. Neurology. 2000 Dec 12;55(11):1748-51. doi: 10.1212/wnl.55.11.1748. Neurology. 2000. PMID: 11113239 Clinical Trial.

7

Aggressive confusional state as a clinical manifestation of status epilepticus in MELAS.

Feddersen B, Bender A, Arnold S, Klopstock T, Noachtar S. Feddersen B, et al. Among authors: klopstock t. Neurology. 2003 Oct 28;61(8):1149-50. doi: 10.1212/01.wnl.0000092497.53706.1b. Neurology. 2003. PMID: 14581687 No abstract available.

8

Mutations in the pantothenate kinase gene PANK2 are not associated with Parkinson disease.

Klopstock T, Elstner M, Lücking CB, Müller-Myhsok B, Gasser T, Botz E, Lichtner P, Hörtnagel K. Klopstock T, et al. Neurosci Lett. 2005 May 13;379(3):195-8. doi: 10.1016/j.neulet.2004.12.061. Neurosci Lett. 2005. PMID: 15843062

9

Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation.

Hartig MB, Hörtnagel K, Garavaglia B, Zorzi G, Kmiec T, Klopstock T, Rostasy K, Svetel M, Kostic VS, Schuelke M, Botz E, Weindl A, Novakovic I, Nardocci N, Prokisch H, Meitinger T. Hartig MB, et al. Among authors: klopstock t. Ann Neurol. 2006 Feb;59(2):248-56. doi: 10.1002/ana.20771. Ann Neurol. 2006. PMID: 16437574

10

Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.

Deutschländer A, Asmus F, Marelli E, Klopstock T, Gasser T, Bötzel K. Deutschländer A, et al. Among authors: klopstock t. Mov Disord. 2006 Sep;21(9):1523-5. doi: 10.1002/mds.20975. Mov Disord. 2006. PMID: 16755578

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

374 results

Search Page

Filters